COVID Olfactory Trial Hints at Possible Benefit

Small sample size limits significance of findings

Recruitment underway for clinical study of PBM for treating long COVID-19

Two Years into the COVID-19 Pandemic: Lessons Learned

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Biomedicines, Free Full-Text

Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age

Clinical trial to restore smell in long COVID patients - Otolaryngology–Head & Neck Surgery

Smell and taste disorders in COVID-19: From pathogenesis to clinical features and outcomes - ScienceDirect

THE PCCA BLOG Post-COVID Loss of Smell: 3 Possible Treatment Op

Intranasal Insulin for the Treatment of Persistent Post‐COVID‐19 Olfactory Dysfunction - Cherobin - 2023 - Otolaryngology–Head and Neck Surgery - Wiley Online Library

COVID-19 and the Chemical Senses: Supporting Players Take Center Stage - ScienceDirect

Frontiers Assessment of COVID-19-related olfactory dysfunction and its association with psychological, neuropsychiatric, and cognitive symptoms

Subcutaneous anti-COVID-19 hyperimmune immunoglobulin for prevention of disease in asymptomatic individuals with SARS-CoV-2 infection: a double-blind, placebo-controlled, randomised clinical trial - eClinicalMedicine

MASH-COVID Trial Hints at Role for Targeting GM-CSF in Hyperinflammatory COVID-19

COVID-19 - Wikipedia